메뉴 건너뛰기
JAMA
Volumn 295, Issue 13, 2006, Pages 1579-1580
Fondaparinux in ST-segment elevation myocardial infarction: The drug, the strategy, the environment, or all of the above?
Author keywords

[No Author keywords available]
Indexed keywords

ENOXAPARIN; FIBRINOLYTIC AGENT; FONDAPARINUX; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; STREPTOKINASE;
EID: 33645503304     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.295.13.jed60020     Document Type: Editorial
Times cited : (11)
References (7)
  • 1
    • 33645497961 scopus 로고    scopus 로고
    • Effects of fondaparinux on mortality and reinfarction in patients with acute ST-segment elevation myocardial infarction: The OASIS-6 randomized trial
    • OASIS-6 Trial Group. Effects of fondaparinux on mortality and reinfarction in patients with acute ST-segment elevation myocardial infarction: The OASIS-6 randomized trial. JAMA. 2006;295:1519-1530.
    • (2006) JAMA , vol.295 , pp. 1519-1530
  • 2
    • 22744458742 scopus 로고    scopus 로고
    • Factor Xa inhibitors in acute coronary syndromes: Moving from mythology to reality
    • Rajagopal V, Bhatt DL. Factor Xa inhibitors in acute coronary syndromes: moving from mythology to reality. J Thromb Haemost. 2005;3:436-438.
    • (2005) J Thromb Haemost , vol.3 , pp. 436-438
    • Rajagopal, V.1    Bhatt, D.L.2
  • 3
    • 12544249141 scopus 로고    scopus 로고
    • Effects of reviparin, a low-molecular-weight heparin, on mortality, reinfarction, and strokes in patients with acute myocardial infarction presenting with ST-segment elevation
    • CREATE Trial Group Investigators. Effects of reviparin, a low-molecular-weight heparin, on mortality, reinfarction, and strokes in patients with acute myocardial infarction presenting with ST-segment elevation. JAMA. 2005;293:427-436.
    • (2005) JAMA , vol.293 , pp. 427-436
  • 4
    • 0031456844 scopus 로고    scopus 로고
    • Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: A quantitative review
    • Weaver WD, Simes RJ, Betriu A, et al. Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review. JAMA. 1997;278:2093-2098.
    • (1997) JAMA , vol.278 , pp. 2093-2098
    • Weaver, W.D.1    Simes, R.J.2    Betriu, A.3
  • 5
    • 2942582865 scopus 로고    scopus 로고
    • A dose-finding study of fondaparinux in patients with non-ST-segment elevation acute coronary syndromes: The Pentasaccharide in Unstable Angina (PENTUA) study
    • Simoons ML, Bobbink IW, Boland J, et al. A dose-finding study of fondaparinux in patients with non-ST-segment elevation acute coronary syndromes: the Pentasaccharide in Unstable Angina (PENTUA) study. J Am Coll Cardiol. 2004;43:2183-2190.
    • (2004) J Am Coll Cardiol , vol.43 , pp. 2183-2190
    • Simoons, M.L.1    Bobbink, I.W.2    Boland, J.3
  • 6
    • 29544437848 scopus 로고    scopus 로고
    • Excess dosing of antiplatelet and antithrombin agents in the treatment of non-ST-segment elevation acute coronary syndromes
    • Alexander KP, Chen AY, Roe MT, et al. Excess dosing of antiplatelet and antithrombin agents in the treatment of non-ST-segment elevation acute coronary syndromes. JAMA. 2005;294:3108-3116.
    • (2005) JAMA , vol.294 , pp. 3108-3116
    • Alexander, K.P.1    Chen, A.Y.2    Roe, M.T.3
  • 7
    • 0037021528 scopus 로고    scopus 로고
    • Integrating quality into the cycle of therapeutic development
    • Califf RM, Peterson ED, Gibbons RJ, et al. Integrating quality into the cycle of therapeutic development. J Am Coll Cardiol. 2002;40:1895-1901.
    • (2002) J Am Coll Cardiol , vol.40 , pp. 1895-1901
    • Califf, R.M.1    Peterson, E.D.2    Gibbons, R.J.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.